project id: TCGA-BRCA; case submitter id: TCGA-B6-A0IM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.1; rna integrity number: 9.6; spectrophotometer method: UV Spec; age at index: 75; days to birth: -27557; days to death: 3873; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1922; age at diagnosis: 27557; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3836.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8523/3; primary diagnosis: Infiltrating duct mixed with other types of carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 1997; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 4754; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-B6-A0IM-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;